Healthcare provider profile · identity verified

Muhammad I Vohra, M.D.

Internal Medicine · HIGHLAND SPRINGS, VA · NPI 1720296155

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	354	43
Atorvastatin Calcium	Atorvastatin Calcium	352	45
Amlodipine Besylate	Amlodipine Besylate	264	36
Metformin Hcl	Metformin Hcl	227	33
Tamsulosin Hcl	Tamsulosin Hcl	219	29
Carvedilol	Carvedilol	215	25
Donepezil Hcl	Donepezil Hcl	215	21
Buspirone Hcl	Buspirone Hcl	206	28
Gabapentin	Gabapentin	201	21
Rosuvastatin Calcium	Rosuvastatin Calcium	199	26
Sertraline Hcl	Sertraline Hcl	195	33
Eliquis	Apixaban	167	26
Furosemide	Furosemide	164	26
Memantine Hcl	Memantine Hcl	146	15
Potassium Chloride	Potassium Chloride	138	29
Metoprolol Tartrate	Metoprolol Tartrate	125	21
Omeprazole	Omeprazole	119	20
Quetiapine Fumarate	Quetiapine Fumarate	111	13
Mirtazapine	Mirtazapine	110	22
Trazodone Hcl	Trazodone Hcl	105	15
Pantoprazole Sodium	Pantoprazole Sodium	104	20
Jardiance	Empagliflozin	94	16
Clopidogrel	Clopidogrel Bisulfate	87	13
Lisinopril	Lisinopril	87	12
Finasteride	Finasteride	84	11
Spironolactone	Spironolactone	84	suppressed
Duloxetine Hcl	Duloxetine Hcl	80	11
Carbidopa-Levodopa	Carbidopa/Levodopa	74	suppressed
Montelukast Sodium	Montelukast Sodium	74	suppressed
Risperidone	Risperidone	71	suppressed
Allopurinol	Allopurinol	70	suppressed
Bumetanide	Bumetanide	65	13
Losartan Potassium	Losartan Potassium	65	13
Metoprolol Succinate	Metoprolol Succinate	63	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	59	11
Trulicity	Dulaglutide	57	11
Midodrine Hcl	Midodrine Hcl	55	15
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Latanoprost	Latanoprost	52	14
Fluoxetine Hcl	Fluoxetine Hcl	51	suppressed
Levetiracetam	Levetiracetam	51	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	47	suppressed
Ibuprofen	Ibuprofen	47	16
Ondansetron Hcl	Ondansetron Hcl	47	33
Simvastatin	Simvastatin	47	suppressed
Lorazepam	Lorazepam	44	suppressed
Baclofen	Baclofen	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Divalproex Sodium	Divalproex Sodium	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Primidone	Primidone	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	23
Cephalexin	Cephalexin	33	18
Bydureon Bcise	Exenatide Microspheres	32	suppressed
Nyamyc	Nystatin	32	15
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Divalproex Sodium Er	Divalproex Sodium	31	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Colchicine	Colchicine	29	suppressed
Famotidine	Famotidine	29	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Azithromycin	Azithromycin	25	15
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Fluconazole	Fluconazole	22	11
Indapamide	Indapamide	22	suppressed
Memantine Hcl Er	Memantine Hcl	22	suppressed
Humalog	Insulin Lispro	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Atenolol	Atenolol	19	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Nystatin	Nystatin	19	11
Torsemide	Torsemide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Clonidine	Clonidine	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Prednisone	Prednisone	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	11
Clonidine Hcl	Clonidine Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Selegiline Hcl	Selegiline Hcl	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Estradiol	Estradiol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Gemtesa	Vibegron	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Ozempic	Semaglutide	11	suppressed
Phenytoin	Phenytoin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error